StemXVivo EMT Inducing Media Supplement (100X)
R&D Systems, part of Bio-Techne | Catalog # CCM017
Key Product Details
Species
Human
Product Summary for StemXVivo EMT Inducing Media Supplement (100X)
Kit Summary
To reliably induce epithelial to mesenchymal transition (EMT) in vitro.
Key Benefits
- Induces EMT in only 5 days
- Is compatible with multiple cell types
- Is a defined formulation to provide consistent EMT induction
Why Induce EMT in vitro with a Defined Media Supplement?
Designed to study EMT in vitro, this media supplement contains a cocktail of EMT-inducing recombinant proteins and neutralizing antibodies for the straightforward induction of EMT in a variety of cell types.
Reliable induction of EMT is useful for understanding the biology of EMT and for identifying and evaluating novel prognostic markers and therapeutics for fibrotic diseases and metastasis. However, the ability to induce EMT in vitro typically requires TGF-beta stimulation or labor-intensive genetic modification. Moreover, although TGF-beta is necessary to induce EMT, it is not sufficient in all cell types.
StemXVivo® EMT Inducing Media Supplement:
- Drives EMT in only 5 days to ensure efficient use of time and reagents.
- Provides a straightforward method to induce EMT in vitro.
- Is completely defined to reduce experimental variability.
- May induce EMT in cells resistant to TGF-beta stimulation alone.
- Avoids time-consuming genetic modifications.
Kit Contents
Components
This defined media supplement contains the following premium quality proteins and high performance neutralizing antibodies to induce EMT:
- Recombinant Human Wnt-5a
- Recombinant Human TGF-beta1
- Anti-Human E-Cadherin
- Anti-Human sFRP-1
- Anti-Human Dkk-1
Each vial contains sufficient volume to drive EMT in the equivalent of fifteen 10 cm diameter tissue culture plates and has been shown to induce EMT in the following human cell lines:
- MCF-7 human breast cancer cells
- MCF-10A human breast epithelial cells
- HT-29 human colon adenocarcinoma cells
- A549 human lung carcinoma cells
- A431 human epithelial carcinoma cells
Scientific Data Images for StemXVivo EMT Inducing Media Supplement (100X)
Induction of Epithelial to Mesenchymal Transition(EMT) in the A549 human lung carcinoma cell line.
The A549 human lung carcinoma cell line was cultured without(A, B); or with(C, D)the StemXVivo®EMT Inducing Media Supplement (Catalog #CCM017) for five days.(A)Control cells exhibit typical epithelial morphology compared to the spindle-shaped, mesenchymal morphology observed in cells following EMT induction(C). EMT status was also assessed by dual immunofluorescence.(B)Untreated cells express the epithelial marker E-Cadherin (red) and exhibit little labeling of the mesenchymal marker Fibronectin (green).D)In contrast, EMT induction results in decreased E-Cadherin expression (red) and an increase in Fibronectin labeling (green). E-Cadherin was detected in cells using a NorthernLights™ (NL) 577-conjugated Goat Anti-Human E-Cadherin Antigen Affinity-purified Polyclonal Antibody (Catalog # NL648R; red). Fibronectin was detected using a Mouse Anti-Human Fibronectin Monoclonal Antibody (Catalog # MAB1918), followed by a NL493-conjugated Donkey Anti-Mouse IgG Secondary Antibody (Catalog # NL009; green). The nuclei were counterstained with DAPI (blue).
Upregulation of the Mesenchymal Markers, Snail and Vimentin, in EMT-induced Cells.
A549 human lung carcinoma and MCF 10A human breast epithelial cells were either untreated or cultured with the StemXVivo®EMT Inducing Media Supplement (Catalog # CCM017) for five days. The cells were analyzed for an epithelial to mesenchymal transition (EMT) by simultaneously staining with the antibodies contained in the Human EMT 3-Color Immunocytochemistry Kit (Catalog # SC026): NorthernLights™ (NL) 637-conjugated Goat Anti-Human E-Cadherin (pseudocolored white), NL557-conjugated Goat Anti-Human Snail (red), and NL493-conjugated Rat Anti-Human Vimentin (green). Cells cultured with the EMT Inducing Media Supplement showed downregulation of the epithelial marker, E-Cadherin, and concurrent upregulation of the mesenchymal markers, Snail and Vimentin, compared to control cells.Formulation, Preparation, and Storage
Shipping
The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Storage
Store the unopened product at -20 to -70 °C. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Do not use past expiration date.
Background: EMT Kits and Reagents
Epithelial to Mesenchymal Transition (EMT) is a biological process which is centrally important to embryogenesis and organ development. Epithelial are highly ordered monolayers of cells with a uniform morphology. Cells within epithelial are characterized by the fact that they are adhered tightly to each other. In contrast, mesenchymal cells differ in shape and display an increased capacity for migration and invasion. This change in phenotype is thought to be involved in some oncogenic pathways. Epithelial to mesenchymal transition allows benign tumors to progress into metastatic cancers that can invade other tissues. EMT is also involved in fibrosis during scar tissue development and may be pathologically relevant to the development of progressive fibrotic diseases. Molecular markers of epithelial to mesenchymal transition include increased expression of N-Cadherin and Vimentin, nuclear localization of beta-catenin, and augmented levels of transcription factors that reduce E-Cadherin expression (i.e. Snail1).
Additional EMT Kits and Reagents Products
Product Documents for StemXVivo EMT Inducing Media Supplement (100X)
Product Specific Notices for StemXVivo EMT Inducing Media Supplement (100X)
For research use only
Loading...
Loading...
Loading...
Loading...
Loading...